A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses

Clinical trial NCT06136403 · RECRUITING

Trial details

NCT number: NCT06136403
Sponsor: Centre Hospitalier Universitaire de Nice
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Simplex Ichthyosis Genodermatosis Inflammatory Congenital Ichthyoses

Start date: 2024-03-18
Primary completion: 2025-09-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.